Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Cancer patients are agreeing to treatment plans lacking a fundamental understanding of the impacts on their finances, explained Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare.
Transcript
Why is it so important to communicate the financial burden of cancer treatment with patients?
The research that we’ve done suggests that patients don’t know what they’re in for, financially, when they’re making treatment decisions. Consider, for example, buying a car. Would you ever buy a car without knowing the price? Would you buy a refrigerator without knowing the price? Patients are signing on to treatment plans without understanding the financial consequences, and that’s just not right. Both ASCO and the academies of medicine have said that talking about cost is fundamental to shared decision making, high-quality cancer care, and a partnership around doing what’s best for the patient. These kinds of issues have to be explored before treatment decisions are made.
What are best practices for successfully communicating and assisting the patient with these burdens?
The team approach to cancer care is key to making sure that patients really understand the implications of treatment decisions. So, once a physician sees a patient, and they talk about a treatment plan, it’s then really important to sit down and understand how the patient can afford this treatment. We have seen practices where there is a team of navigators, nurses, or financial aid folks that come in and talk to the patients and take them through their co-pays, deductibles, and formulary issues, and help them understand what the impact of treatment will be on their finances.
If that isn’t done, then patients are blind-sided and often suffer the consequences for years. It takes a village. Cancer care is very complex. Patients are overwhelmed with the emotional, physical, spiritual, family, and financial aspects of being sick, and there are many resources that can help support patients on many levels. Patients need to know about them. Providers need to help them understand that these resources exist, and they can make the experience of having cancer less difficult for patients if they know about and avail themselves of these resources.
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More